WASHINGTON (July 21)—Inamed Corp., the Santa Barbara, Calif.-based medical device manufacturer, is waiting to hear whether the U.S. Food and Drug Administration will grant its petition to approve silicone-gel breast implants for general sale in the U.S. Mentor Corp., also based in Santa Barbara, is expected to submit its own petition on silicone implants to the FDA. But groups such as Public Citizen and the National Organization for Women feel the FDA still hasn't answered lingering questions about the safety of the devices, access to which it restricted severely in 1992. "Silicone breast implants have been in clinical trials for 11 years," said Diana Zuckerman, director of the Center for Policy Research for Women and Families. "There should be 11 years of good data. Why did they only require two, three or four years of study under the circumstances?"
Manufacturers, activists spar once again over silicone breast implants
Rubber & Plastics News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected].